Platelets are not critical effector cells for the time course of murine passive crescentic glomerulonephritis

References

• Couser WG. Mediation of immune glomerular injury. J Am Soc Nephrol 1990; 1(1)13–29
   PubMedGoogle Scholar
• Couser WG. Pathogenesis of glomerular damage in glomerulonephritis. Nephrol Dial Transplant 1998; 13(Suppl 1)10–15
   PubMedGoogle Scholar
• Couser WG, Johnson RJ. Mechanisms of progressive renal disease in glomerulonephritis. Am J Kidney Dis 1994; 23(2)193–198
   PubMedGoogle Scholar
• Ophascharoensuk V, Pippin JW, Gordon KL, Shankland SJ, Couser WG, Johnson RJ. Role of intrinsic renal cells versus infiltrating cells in glomerular crescent formation. Kidney Int 1998; 54(2)416–425
   PubMedGoogle Scholar
• Hohenstein B, Renk S, Lang K, Daniel C, Freund M, Leon C, Amann KU, Gachet C, Hugo CP. P2Y1 gene deficiency protects from renal disease progression and capillary rarefaction during passive crescentic glomerulonephritis. J Am Soc Nephrol 2007; 18(2)494–505
   PubMedGoogle Scholar
• Barnes JL. Platelets in glomerular disease. Nephron 1997; 77(4)378–393
   PubMed Web of Science ®Google Scholar
• Barnes JL, Venkatachalam MA. The role of platelets and polycationic mediators in glomerular vascular injury. Semin Nephrol 1985; 5(1)57–68
   PubMedGoogle Scholar
• Johnson RJ. Platelets in inflammatory glomerular injury. Semin Nephrol 1991; 11(3)276–284
   PubMedGoogle Scholar
• Johnson RJ. The glomerular response to injury: Progression or resolution?. Kidney Int 1994; 45(6)1769–1782
   PubMedGoogle Scholar
• Hohenstein B, Kasperek L, Kobelt DJ, Daniel C, Gambaryan S, Renne T, Walter U, Amann KU, Hugo CP. Vasodilator-stimulated phosphoprotein-deficient mice demonstrate increased platelet activation but improved renal endothelial preservation and regeneration in passive nephrotoxic nephritis. J Am Soc Nephrol 2005; 16(4)986–996. Epub 2005/03/04
   PubMedGoogle Scholar
• Bergmeier W, Rackebrandt K, Schroder W, Zirngibl H, Nieswandt B. Structural and functional characterization of the mouse von Willebrand factor receptor GPIb-IX with novel monoclonal antibodies. Blood 2000; 95(3)886–893
   PubMed Web of Science ®Google Scholar
• Nieswandt B, Bergemeier W, Rackebrandt K, Gessner JE, Zirngibl H. Identification of critical antigen-specific mechanisms in the development of immune thrombocytopenic purpura in mice. Blood 2000; 96(7)2520–2527
   PubMedGoogle Scholar
• Massberg S, Brand K, Gruner S, Page S, Muller E, Muller I, Bergmeier W, Richter T, Lorenz M, Konrad I, et al. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med 2002; 196(7)887–896
   PubMed Web of Science ®Google Scholar
• Hugo C, Pichler R, Meek R, Gordon K, Kyriakides T, Floege J, Bornstein P, Couser WG, Johnson RJ. Thrombospondin 1 is expressed by proliferating mesangial cells and is up-regulated by PDGF and bFGF in vivo. Kidney Int 1995; 48(6)1846–1856
   PubMedGoogle Scholar
• Hallmann R, Mayer DN, Berg EL, Broermann R, Butcher EC. Novel mouse endothelial cell surface marker is suppressed during differentiation of the blood brain barrier. Dev Dyn 1995; 202(4)325–332
   PubMedGoogle Scholar
• Thurston G, Murphy TJ, Baluk P, Lindsey JR, McDonald DM. Angiogenesis in mice with chronic airway inflammation: Strain-dependent differences. Am J Pathol 1998; 153(4)1099–1112
   PubMedGoogle Scholar
• Kim YG, Suga SI, Kang DH, Jefferson JA, Mazzali M, Gordon KL, Matsui K, Breiteneder-Geleff S, Shankland SJ, Hughes J, et al. Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy. Kidney Int 2000; 58(6)2390–2399
   PubMed Web of Science ®Google Scholar
• Weibel ER. Practical methods for biological morphometry. Academic Press, London 1979
   Google Scholar
• Weibel ER. Theoretical foundations. Academic Press, London 1979
   Google Scholar
• Amann K, Koch A, Hofstetter J, Gross ML, Haas C, Orth SR, Ehmke H, Rump LC, Ritz E. Glomerulosclerosis and progression: Effect of subantihypertensive doses of alpha and beta blockers. Kidney Int 2001; 60(4)1309–1323
   PubMedGoogle Scholar
• Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein–dye binding. Anal Biochem 1976; 72: 248–254
   PubMed Web of Science ®Google Scholar
• Schleicher E, Wieland OH. Evaluation of the Bradford method for protein determination in body fluids. J Clin Chem Clin Biochem 1978; 16(9)533–534
   PubMedGoogle Scholar
• Kang DH, Kanellis J, Hugo C, Truong L, Anderson S, Kerjaschki D, Schreiner GF, Johnson RJ. Role of the microvascular endothelium in progressive renal disease. J Am Soc Nephrol 2002; 13(3)806–816
   PubMed Web of Science ®Google Scholar
• Johnson RJ, Alpers CE, Pritzl P, Schulze M, Baker P, Pruchno C, Couser WG. Platelets mediate neutrophil-dependent immune complex nephritis in the rat. J Clin Invest 1988; 82(4)1225–1235
   PubMedGoogle Scholar
• Johnson RJ, Garcia RL, Pritzl P, Alpers CE. Platelets mediate glomerular cell proliferation in immune complex nephritis induced by anti-mesangial cell antibodies in the rat. Am J Pathol 1990; 136(2)369–374
   PubMedGoogle Scholar
• Hauser W, Knobeloch KP, Eigenthaler M, Gambaryan S, Krenn V, Geiger J, Glazova M, Rohde E, Horak I, Walter U, et al. Megakaryocyte hyperplasia and enhanced agonist-induced platelet activation in vasodilator-stimulated phosphoprotein knockout mice. Proc Natl Acad Sci USA 1999; 96(14)8120–8125
   PubMedGoogle Scholar
• Leon C, Hechler B, Freund M, Eckly A, Vial C, Ohlmann P, Dierich A, LeMeur M, Cazenave JP, Gachet C. Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice. J Clin Invest 1999; 104(12)1731–1737
   PubMedGoogle Scholar
• Peters H, Eisenberg R, Daig U, Liefeldt L, Westenfeld R, Gaedeke J, Kramer S, Neumayer HH. Platelet inhibition limits TGF-beta overexpression and matrix expansion after induction of anti-thy1 glomerulonephritis. Kidney Int 2004; 65(6)2238–2248
   PubMedGoogle Scholar
• Cattell V. Focal mesangial proliferative glomerulonephritis in the rat caused by Habu snake venom: The role of platelets. Br J Exp Pathol 1979; 60(2)201–208
   PubMedGoogle Scholar
• Cattell V, Mehotra A. Focal mesangial proliferative glomerulonephritis in the rat caused by Habu venom: The effect of antiplatelet agents. Br J Exp Pathol 1980; 61(3)310–314
   PubMedGoogle Scholar
• Barnes JL, Hevey KA. Glomerular mesangial cell migration. Response to platelet secretory products. Am J Pathol 1991; 138(4)859–866
   Google Scholar
• Kitamura M, Fine LG. The concept of glomerular self-defense. Kidney Int 1999; 55(5)1639–1671
   PubMedGoogle Scholar
• Chan MK, Kwan SY, Chan KW, Yeung CK. Controlled trial of antiplatelet agents in mesangial IgA glomerulonephritis. Am J Kidney Dis 1987; 9(5)417–421
   PubMedGoogle Scholar
• Harker LA. Antiplatelet drugs in the management of patients with thrombotic disorders. Semin Thromb Hemost 1986; 12(2)134–155
   PubMedGoogle Scholar
• Ueda N, Kawaguchi S, Niinomi Y, Nonoda T, Ohnishi M, Ito S, Yasaki T. Effect of dipyridamole treatment on proteinuria in pediatric renal disease. Nephron 1986; 44(3)174–179
   PubMedGoogle Scholar
• Hohenstein B, Braun A, Amann KU, Johnson RJ, Hugo CP. A murine model of site-specific renal microvascular endothelial injury and thrombotic microangiopathy. Nephrol Dial Transplant 2008; 23(4)1144–1156
   PubMed Web of Science ®Google Scholar